Update July 23, 2012: The 2012 PreCede grant competition has closed. Awards were announced in July 2012. Awards are subject to specific grant agreement terms and conditions and are contingent pending final grant agreement execution.
New for 2012, the PreCede grant competition is designed to help position early-stage Washington state life sciences companies for near-term equity investment. PreCede grants will support research and development activities focused on validating the commercial merit of promising health-related technologies, such as proof of concept studies or prototype construction and testing.
This competition is open to for-profit entities that meet the following criteria:
- Pursuing development-stage health or health-care related products or services;
- Have a substantial presence in Washington;
- Have not received substantial equity investment.
Non-profit organizations and educational institutions may not apply directly for funding through the PreCede grant competition.
LSDF has allocated up to $300,000 for the 2012 PreCede grant competition. Individual requests are not to exceed $150,000, with work expected to be completed within one year. Pre-proposals are required. Only a subset of pre-proposals will be invited to submit a full proposal.
PowerPoint presentation (PDF) from the informational webcast on January 10, 2012
LSDF Announces 2012 PreCede Grant Competition Invitees
|Principal Investigator||Organization||Pre-Proposal Title|
|Robert Abbott||Nova TheraNostics, LLC||Commercialization of NTN-101, a Gd-Lipid Nanoparticle Product for Safer and More Effective Contrast MRI|
|Andrew Face||Crux Medical Innovations||Crux Medical Innovations Multiple Core Biopsy Device|
|Alistair Hirst||KineMotion Health, Inc.||Home Physical Therapy Assistant|
|Glenn Kawasaki||Carepeutics, Inc.||Drug Distribution and Activity in Cancer Patients|
|Deborah Kessler||Guide Analytics, Inc.||Improving Heart Failure Self-Care|
|Tom Sanko||Harpoon Navigation, Inc.||A Test in Humans of a Disposable, Ultrasound-Guided Catheter|
|Thomas Schulte||Nexgenia, Inc.||The Scale-up and Optimization of Smart Magnetic Nanoparticle Synthesis|
|Robert Wilcox||Viket Medical Corp.||MITT - Minimally Invasive Transcranial Thrombectomy|